Alpine Immune Sciences Inc
(NAS:ALPN)
$
64.94
0.12 (0.19%)
Market Cap: 4.45 Bil
Enterprise Value: 4.16 Bil
PE Ratio: 0
PB Ratio: 11.95
GF Score: 61/100 Alpine Immune Sciences Inc at Wedbush PacGrow Healthcare Conference (Virtual) Transcript
Aug 10, 2022 / 08:05PM GMT
Release Date Price:
$8.8
(+3.65%)
Robert Driscoll
Wedbush Securities Inc. - Analyst
Thanks for joining us here at the Wedbush PacGrow Healthcare Conference 2022. My name is Robert Driscoll, one of the senior analysts here at Wedbush, and I have the pleasure of hosting Alpine Immune Sciences here today for their virtual fireside.
With us from Alpine, we've got Remy Durand, Chief Business Officer here at Alpine. (Conference Instructions)
So welcome, Remy, thanks for joining us today.
Remy Durand
Alpine Immune Sciences, Inc. - Chief Business Officer
Hi, Robert. Thank you very much for having us today.
Questions & Answers
Robert Driscoll
Wedbush Securities Inc. - Analyst
Great. So maybe just for those who are unfamiliar with the company, can you introduce us to the drug discovery platform here at Alpine and maybe a quick snapshot of where you guys are today.
Remy Durand
Alpine Immune Sciences, Inc. - Chief Business Officer
Yes, absolutely. Alpine was actually started in 2015
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot